All the Active Ingredient Drugs
Phosphodiesterase-5 Enzyme Inhibitor. Vardenafil (as HCl) 5 mg, 10 mg, 20 mg. TABS: 2, 4 x 5 mg, 10 mg; 8 x 20 mg.
Recommend. start. dose: 10 mg 25-60 mins. bef. intercourse. May incr. to 20 mg or decr. to 5 mg. Max: 20 mg/day.
Max: 1 x dly. Over 65 yrs: Initial: 5 mg.
Tmt. of erectile dysfunct. In order for the drug to be effective, sexual stimul. is required. Not indicated for use by women.
C/I: Hypersens. Co-admin. with nitrates, nitric oxide donors (e.g. as amyl nitrite). Pts. who have loss of vision in one eye because of non-arteritic anter. ischem. optic neuropathy (NAION), regardless of whether this episode was in connect. or not with prev. phosphodiesterase 5 (PDE5) inhib.
Meds. products for the tmt. of erectile dysfunct. should general. not be used in men for whom sex. activ. is inadvis. (e.g. pts. with sev. cardiovasc. disord. such as unstab. angina or sev. card. fail. [NYHA III or IV]).
Severe hep. impair. (Child-Pugh C), end stage ren. dis. requir. dialys., hypotens. (BP 90/50 mmHg), Recent hist. of stroke or MI (within the last 6 mnths.), unstab. ang. and known hered. retin. degenerate. disord. such as retinit. pigmentosa.
Concom. use with the potent CYP3A4 inhib. ketoconazole & itraconazole (oral form) is contraind. in men older than 75 yrs.
Concom. use with HIV protease inhib. such as ritonavir & indinavir. Co-admin. of PDE5 inhib., with guanylate cyclase stimulat., (e.g. riociguat).
Phosphodiesterase-5 Enzyme Inhibitor. Vardenafil 10 mg. ORODISPERSIBLE TABS: 4. Recommend. dose: 1 orodisp. tab. 25-60 mins. bef. intercourse. Max: 1 x dly (with/out food).
Tmt. of erectile dysfunct. In order for the drug to be effective, sexual stimul. is required. Not indicated for use by women.
C/I: Hypersens. Co-admin. with nitrates, nitric oxide donors (e.g. as amyl nitrite). Pts. who have loss of vision in one eye because of non-arteritic anter. ischem. optic neuropathy (NAION), regardless of whether this episode was in connect. or not with prev. phosphodiesterase 5 (PDE5) inhib.
Meds. products for the tmt. of erectile dysfunct. should general. not be used in men for whom sex. activ. is inadvis. (e.g. pts. with sev. cardiovasc. disord. such as unstab. angina or sev. card. fail. [NYHA III or IV]).
Severe hep. impair. (Child-Pugh C), end stage ren. dis. requir. dialys., hypotens. (BP 90/50 mmHg), Recent hist. of stroke or MI (within the last 6 mnths.), unstab. ang. and known hered. retin. degenerate. disord. such as retinit. pigmentosa.
Concom. use with the potent CYP3A4 inhib. ketoconazole & itraconazole (oral form) is contraind. in men older than 75 yrs.
Concom. use with HIV protease inhib. such as ritonavir & indinavir.
Co-admin. of PDE5 inhib., with guanylate cyclase stimulat., (e.g. riociguat).
